The January collection of @picujournalwatch.bsky.social is on this link www.picujournalwatch.com/journalwatch..., with the Article of the month www.picujournalwatch.com/journalwatch..., #NeuroPICU #pedPICU #sepsis articles and many more!
PICUJournalWatch - latest
JANUARY 2025
Trash in/trash out? Using routinely collected clinical data for data science in the ICU: Con - PubMed
Evaluation of Phoenix Sepsis Score Criteria: Exploratory Analysis of Characteristics...
www.picujournalwatch.com
February 3, 2025 at 7:42 PM
The January collection of @picujournalwatch.bsky.social is on this link www.picujournalwatch.com/journalwatch..., with the Article of the month www.picujournalwatch.com/journalwatch..., #NeuroPICU #pedPICU #sepsis articles and many more!
Great February collection from the @picujournalwatch.bsky.social team featuring #ECMO #CICU #NeuroICU #NICU and much more on this link: picujournalwatch.com/journalwatch.... #STARSHIP is the ArticleOfTheMonth: picujournalwatch.com/journalwatch... @picujournalwatch.bsky.social
picujournalwatch.com
March 3, 2025 at 5:40 PM
Great February collection from the @picujournalwatch.bsky.social team featuring #ECMO #CICU #NeuroICU #NICU and much more on this link: picujournalwatch.com/journalwatch.... #STARSHIP is the ArticleOfTheMonth: picujournalwatch.com/journalwatch... @picujournalwatch.bsky.social
Here is our June 2025 #PICUJournalWatch collection! picujournalwatch.com/journalwatch.... Topics inc. enteral nutrition, PICU survival & CPR. AOTM: REDvent - an RCT on lung and diaphragm protection
picujournalwatch.com/journalwatch... in @NEJMEvidence. Enjoy!
@picujournalwatch.bsky.social
picujournalwatch.com/journalwatch... in @NEJMEvidence. Enjoy!
@picujournalwatch.bsky.social
picujournalwatch.com
July 8, 2025 at 1:58 AM
Here is our June 2025 #PICUJournalWatch collection! picujournalwatch.com/journalwatch.... Topics inc. enteral nutrition, PICU survival & CPR. AOTM: REDvent - an RCT on lung and diaphragm protection
picujournalwatch.com/journalwatch... in @NEJMEvidence. Enjoy!
@picujournalwatch.bsky.social
picujournalwatch.com/journalwatch... in @NEJMEvidence. Enjoy!
@picujournalwatch.bsky.social
The July collection of @picujournalwatch.bsky.social
is now available to view on this link picujournalwatch.com/journalwatch.... We chose (IsoCOMFORT) as the ArticleOfTheMonth, available on this link as well as the PICCHub app: picujournalwatch.com/journalwatch... @picujournalwatch.bsky.social
is now available to view on this link picujournalwatch.com/journalwatch.... We chose (IsoCOMFORT) as the ArticleOfTheMonth, available on this link as well as the PICCHub app: picujournalwatch.com/journalwatch... @picujournalwatch.bsky.social
picujournalwatch.com
August 23, 2025 at 1:37 PM
The July collection of @picujournalwatch.bsky.social
is now available to view on this link picujournalwatch.com/journalwatch.... We chose (IsoCOMFORT) as the ArticleOfTheMonth, available on this link as well as the PICCHub app: picujournalwatch.com/journalwatch... @picujournalwatch.bsky.social
is now available to view on this link picujournalwatch.com/journalwatch.... We chose (IsoCOMFORT) as the ArticleOfTheMonth, available on this link as well as the PICCHub app: picujournalwatch.com/journalwatch... @picujournalwatch.bsky.social
For #JournalWatch this January, #ISHLTEarlyCareer contributors explore topics in #Cardiology. Thanks to Juan Carlos de la Fuente Mancera for leading the issue, and @adityamehtamd.bsky.social/Juan B Ivey-Miranda for their contributions!
#CardiacAMR #HeartTx #DonorSpecificAntibodies #CardioSky #MedSky
#CardiacAMR #HeartTx #DonorSpecificAntibodies #CardioSky #MedSky
January Journal Watch Explores Recent Cardiology Topics
Edited by Juan Carlos de la Fuente Mancera, MD, the January 2025 Journal Watch explores topics in Cardiology.
www.ishlt.org
January 27, 2025 at 1:57 PM
For #JournalWatch this January, #ISHLTEarlyCareer contributors explore topics in #Cardiology. Thanks to Juan Carlos de la Fuente Mancera for leading the issue, and @adityamehtamd.bsky.social/Juan B Ivey-Miranda for their contributions!
#CardiacAMR #HeartTx #DonorSpecificAntibodies #CardioSky #MedSky
#CardiacAMR #HeartTx #DonorSpecificAntibodies #CardioSky #MedSky
For #JournalWatch this month, #ISHLTEarlyCareer contributors explored topics in transplant #Anesthesiology and #CriticalCare. Thanks to @alingrag.bsky.social for leading the issue, and @codonnell1130.bsky.social/Robert Arrigo/Emily Stephenson for their contributions!
www.ishlt.org/about/news-d...
www.ishlt.org/about/news-d...
Recent Studies in Cardiothoracic Anesthesiology & Critical Care
Edited by Alin Gragossian, DO, MPH, the March 2025 Journal Watch explores topics in Anesthesiology & Critical Care.
www.ishlt.org
March 31, 2025 at 3:20 PM
For #JournalWatch this month, #ISHLTEarlyCareer contributors explored topics in transplant #Anesthesiology and #CriticalCare. Thanks to @alingrag.bsky.social for leading the issue, and @codonnell1130.bsky.social/Robert Arrigo/Emily Stephenson for their contributions!
www.ishlt.org/about/news-d...
www.ishlt.org/about/news-d...
The topics of articles selected for Pancreatobiliary Pathology Society Journal Watch
pbpath.org/journal-watc...
#pbpath #pancreas #pathology #pancreatobiliary #society #journalwatch #articles #vosviewer #bibliometrics
pbpath.org/journal-watc...
#pbpath #pancreas #pathology #pancreatobiliary #society #journalwatch #articles #vosviewer #bibliometrics
November 10, 2024 at 9:04 AM
The topics of articles selected for Pancreatobiliary Pathology Society Journal Watch
pbpath.org/journal-watc...
#pbpath #pancreas #pathology #pancreatobiliary #society #journalwatch #articles #vosviewer #bibliometrics
pbpath.org/journal-watc...
#pbpath #pancreas #pathology #pancreatobiliary #society #journalwatch #articles #vosviewer #bibliometrics
June's #JournalWatch is out now, exploring topics in #cardiothoracic #Nursing and #AlliedHealth from #ISHLTEarlyCareer professionals.
www.ishlt.org/about/news-d...
www.ishlt.org/about/news-d...
ISHLT Journal Watch topics in cardiothoracic transplantation Nursing and Allied Health
Topics include health literacy in transplant candidates, donor heart refusal in the US, and the lived experience of cystic fibrosis patients after lung transplant.
www.ishlt.org
June 30, 2025 at 2:04 PM
June's #JournalWatch is out now, exploring topics in #cardiothoracic #Nursing and #AlliedHealth from #ISHLTEarlyCareer professionals.
www.ishlt.org/about/news-d...
www.ishlt.org/about/news-d...
July's #ISHLT #JournalWatch is out now, exploring topics in #cardiothoracic #pediatric #transplant from #ISHLTEarlyCareer professionals. Thanks to issue editor Hugo Martinez, and contributors Majid Husain, Kathryn Restaino, Sowmith Rangu, and Jared Sheridan.
www.ishlt.org/about/news-d...
www.ishlt.org/about/news-d...
Early Career-led review of literature in Pediatric Transplantation
Topics include lung transplant for interstitial lung disease, MCS outcomes using pCF pumps, 38 years of data on pediatric heart transplant from Scandinavia, and more.
www.ishlt.org
July 28, 2025 at 2:49 PM
July's #ISHLT #JournalWatch is out now, exploring topics in #cardiothoracic #pediatric #transplant from #ISHLTEarlyCareer professionals. Thanks to issue editor Hugo Martinez, and contributors Majid Husain, Kathryn Restaino, Sowmith Rangu, and Jared Sheridan.
www.ishlt.org/about/news-d...
www.ishlt.org/about/news-d...
In the final study from last month's #CTSurgery #ISHLTJournalWatch, Anna Niroomand reviews the latest literature in @naturemedicine.bsky.social on pig-to-human #xenotransplantation of the #lung. 🫁
#LungTx #ISHLT #TransplantSky #PulmSky
#LungTx #ISHLT #TransplantSky #PulmSky
October 20, 2025 at 9:30 PM
In the final study from last month's #CTSurgery #ISHLTJournalWatch, Anna Niroomand reviews the latest literature in @naturemedicine.bsky.social on pig-to-human #xenotransplantation of the #lung. 🫁
#LungTx #ISHLT #TransplantSky #PulmSky
#LungTx #ISHLT #TransplantSky #PulmSky
The final study reviews the distinct experiences people with #CysticFibrosis encounter before & after #LungTx, highlighting their unique physical/emotional challenges, and suggesting what #transplant nurses and psychologists can do to support them.
For more: www.ishlt.org/education-an... #ISHLT
For more: www.ishlt.org/education-an... #ISHLT
July 14, 2025 at 2:47 PM
The final study reviews the distinct experiences people with #CysticFibrosis encounter before & after #LungTx, highlighting their unique physical/emotional challenges, and suggesting what #transplant nurses and psychologists can do to support them.
For more: www.ishlt.org/education-an... #ISHLT
For more: www.ishlt.org/education-an... #ISHLT
#JournalWatch #CHD
📌 Liver maximum function capacity test (LiMAx®) → new “breath test” in which 13C-methacetin is cleaved by hepatic cytochrome P450 1A2 to paracetamol and 13CO2 (which is measured in exhaled air)
👥 39 adult Fontan patients (median age 29.4 years)
📌 Liver maximum function capacity test (LiMAx®) → new “breath test” in which 13C-methacetin is cleaved by hepatic cytochrome P450 1A2 to paracetamol and 13CO2 (which is measured in exhaled air)
👥 39 adult Fontan patients (median age 29.4 years)
December 2, 2024 at 2:24 PM
#JournalWatch #CHD
📌 Liver maximum function capacity test (LiMAx®) → new “breath test” in which 13C-methacetin is cleaved by hepatic cytochrome P450 1A2 to paracetamol and 13CO2 (which is measured in exhaled air)
👥 39 adult Fontan patients (median age 29.4 years)
📌 Liver maximum function capacity test (LiMAx®) → new “breath test” in which 13C-methacetin is cleaved by hepatic cytochrome P450 1A2 to paracetamol and 13CO2 (which is measured in exhaled air)
👥 39 adult Fontan patients (median age 29.4 years)
#JournalWatch #StructuralHeart
📌 RV-PA coupling ratio (TAPSE/PASP)
👥 444 patients with TR undergoing TTVR in the TriValve registry
👉 TAPSE/PASP ratio >0.406 and (surprisingly!) a decrease in ratio after TTVR associated with lower all-cause mortality
📌 RV-PA coupling ratio (TAPSE/PASP)
👥 444 patients with TR undergoing TTVR in the TriValve registry
👉 TAPSE/PASP ratio >0.406 and (surprisingly!) a decrease in ratio after TTVR associated with lower all-cause mortality
December 2, 2024 at 2:25 PM
#JournalWatch #StructuralHeart
📌 RV-PA coupling ratio (TAPSE/PASP)
👥 444 patients with TR undergoing TTVR in the TriValve registry
👉 TAPSE/PASP ratio >0.406 and (surprisingly!) a decrease in ratio after TTVR associated with lower all-cause mortality
📌 RV-PA coupling ratio (TAPSE/PASP)
👥 444 patients with TR undergoing TTVR in the TriValve registry
👉 TAPSE/PASP ratio >0.406 and (surprisingly!) a decrease in ratio after TTVR associated with lower all-cause mortality
#JournalWatch #CHD
📌 New RACHS-2 stratification system!
👉 ICD-10 based → cheap and easy
👉 Prediction of operative mortality with C-statistic of 0.76 in training and 0.84 in validation (similar to STAT Mortality Categories
📌 New RACHS-2 stratification system!
👉 ICD-10 based → cheap and easy
👉 Prediction of operative mortality with C-statistic of 0.76 in training and 0.84 in validation (similar to STAT Mortality Categories
December 2, 2024 at 2:25 PM
#JournalWatch #CHD
📌 New RACHS-2 stratification system!
👉 ICD-10 based → cheap and easy
👉 Prediction of operative mortality with C-statistic of 0.76 in training and 0.84 in validation (similar to STAT Mortality Categories
📌 New RACHS-2 stratification system!
👉 ICD-10 based → cheap and easy
👉 Prediction of operative mortality with C-statistic of 0.76 in training and 0.84 in validation (similar to STAT Mortality Categories
#JournalWatch #AF
📌 NOAC Bleeding Prediction (NBP) Calculator → new risk score to predict bleeding risk in AF patients being prescribed NOACs
👉 model AUC = 0.66 on internal validation, 0.61-0.62 on external validation; compared to 0.58 for HAS-BLED and 0.57 for CHA2DS2-VASc
📌 NOAC Bleeding Prediction (NBP) Calculator → new risk score to predict bleeding risk in AF patients being prescribed NOACs
👉 model AUC = 0.66 on internal validation, 0.61-0.62 on external validation; compared to 0.58 for HAS-BLED and 0.57 for CHA2DS2-VASc
December 2, 2024 at 2:24 PM
#JournalWatch #AF
📌 NOAC Bleeding Prediction (NBP) Calculator → new risk score to predict bleeding risk in AF patients being prescribed NOACs
👉 model AUC = 0.66 on internal validation, 0.61-0.62 on external validation; compared to 0.58 for HAS-BLED and 0.57 for CHA2DS2-VASc
📌 NOAC Bleeding Prediction (NBP) Calculator → new risk score to predict bleeding risk in AF patients being prescribed NOACs
👉 model AUC = 0.66 on internal validation, 0.61-0.62 on external validation; compared to 0.58 for HAS-BLED and 0.57 for CHA2DS2-VASc
#JournalWatch #CardiovascularRisk
📌 “Don’t Worry, Be Happy”
👥 1561 men from the NAS prospective cohort
👉 neuroticism and worry were associated with higher cardiometabolic risk (CMR)
📌 “Don’t Worry, Be Happy”
👥 1561 men from the NAS prospective cohort
👉 neuroticism and worry were associated with higher cardiometabolic risk (CMR)
December 2, 2024 at 2:24 PM
#JournalWatch #CardiovascularRisk
📌 “Don’t Worry, Be Happy”
👥 1561 men from the NAS prospective cohort
👉 neuroticism and worry were associated with higher cardiometabolic risk (CMR)
📌 “Don’t Worry, Be Happy”
👥 1561 men from the NAS prospective cohort
👉 neuroticism and worry were associated with higher cardiometabolic risk (CMR)
#JournalWatch #CKD #CardiovascularRisk
👥 176 participants (stage 4-5 CKD, not on dialysis, >65yo) in EQUAL study
👉 cTnT at any time point (HR 3.3), the slope (HR 3.2), and the AUC of its trajectory (HR 4.2) were all associated with mortality
👥 176 participants (stage 4-5 CKD, not on dialysis, >65yo) in EQUAL study
👉 cTnT at any time point (HR 3.3), the slope (HR 3.2), and the AUC of its trajectory (HR 4.2) were all associated with mortality
December 2, 2024 at 2:24 PM
#JournalWatch #CKD #CardiovascularRisk
👥 176 participants (stage 4-5 CKD, not on dialysis, >65yo) in EQUAL study
👉 cTnT at any time point (HR 3.3), the slope (HR 3.2), and the AUC of its trajectory (HR 4.2) were all associated with mortality
👥 176 participants (stage 4-5 CKD, not on dialysis, >65yo) in EQUAL study
👉 cTnT at any time point (HR 3.3), the slope (HR 3.2), and the AUC of its trajectory (HR 4.2) were all associated with mortality
#JournalWatch #ACS
👥 6,544 patients with NSTEMI in KAMIR-NIH
👉 27.9% had symptom-to-door time >24h, which was associated w higher 3-year all-cause mortality, recurrent MI, and HFH
👉 elderly, women, atypical chest pain or dyspnea, DM, and no EMS use were associated with delay
👥 6,544 patients with NSTEMI in KAMIR-NIH
👉 27.9% had symptom-to-door time >24h, which was associated w higher 3-year all-cause mortality, recurrent MI, and HFH
👉 elderly, women, atypical chest pain or dyspnea, DM, and no EMS use were associated with delay
December 2, 2024 at 2:24 PM
#JournalWatch #ACS
👥 6,544 patients with NSTEMI in KAMIR-NIH
👉 27.9% had symptom-to-door time >24h, which was associated w higher 3-year all-cause mortality, recurrent MI, and HFH
👉 elderly, women, atypical chest pain or dyspnea, DM, and no EMS use were associated with delay
👥 6,544 patients with NSTEMI in KAMIR-NIH
👉 27.9% had symptom-to-door time >24h, which was associated w higher 3-year all-cause mortality, recurrent MI, and HFH
👉 elderly, women, atypical chest pain or dyspnea, DM, and no EMS use were associated with delay
#JournalWatch #CHD
👥 158 adults with SRV; 21 met combined endpoint (HT referral, VAD, or death) after 8.5 years
👉 AUCs for RVEDVi, RVESVi, RVEF, RV mass were 0.93, 0.90, 0.73, 0.84 for D-TGA and 0.76, 0.74, 0.71, 0.74 for ccTGA
👉 RVEDVi of 132 and 126 mL/m² for D-TGA and ccTGA
👥 158 adults with SRV; 21 met combined endpoint (HT referral, VAD, or death) after 8.5 years
👉 AUCs for RVEDVi, RVESVi, RVEF, RV mass were 0.93, 0.90, 0.73, 0.84 for D-TGA and 0.76, 0.74, 0.71, 0.74 for ccTGA
👉 RVEDVi of 132 and 126 mL/m² for D-TGA and ccTGA
December 2, 2024 at 2:24 PM
#JournalWatch #CHD
👥 158 adults with SRV; 21 met combined endpoint (HT referral, VAD, or death) after 8.5 years
👉 AUCs for RVEDVi, RVESVi, RVEF, RV mass were 0.93, 0.90, 0.73, 0.84 for D-TGA and 0.76, 0.74, 0.71, 0.74 for ccTGA
👉 RVEDVi of 132 and 126 mL/m² for D-TGA and ccTGA
👥 158 adults with SRV; 21 met combined endpoint (HT referral, VAD, or death) after 8.5 years
👉 AUCs for RVEDVi, RVESVi, RVEF, RV mass were 0.93, 0.90, 0.73, 0.84 for D-TGA and 0.76, 0.74, 0.71, 0.74 for ccTGA
👉 RVEDVi of 132 and 126 mL/m² for D-TGA and ccTGA
#JournalWatch #CHD
📌 PREVENTION-ACHD risk score model
👥 model developed based on risk factors identified in PREVENTION-ACHD registry and data regarding baseline hazard from CONCOR registry
📌 PREVENTION-ACHD risk score model
👥 model developed based on risk factors identified in PREVENTION-ACHD registry and data regarding baseline hazard from CONCOR registry
December 2, 2024 at 2:24 PM
#JournalWatch #CHD
📌 PREVENTION-ACHD risk score model
👥 model developed based on risk factors identified in PREVENTION-ACHD registry and data regarding baseline hazard from CONCOR registry
📌 PREVENTION-ACHD risk score model
👥 model developed based on risk factors identified in PREVENTION-ACHD registry and data regarding baseline hazard from CONCOR registry
#JournalWatch #Cardiology
📌 Network Meta-Analysis of 4 pivotal RCTs of DOACs vs warfarin in AF
👉 Standard-dose DOACs: ⬇️ stroke/embolism, death, intracranial bleeding; ❌ major bleeding
👉 Low-dose DOACs: ⬇️ death, intracranial bleeding, major bleeding; ❌ stroke/embolism
📌 Network Meta-Analysis of 4 pivotal RCTs of DOACs vs warfarin in AF
👉 Standard-dose DOACs: ⬇️ stroke/embolism, death, intracranial bleeding; ❌ major bleeding
👉 Low-dose DOACs: ⬇️ death, intracranial bleeding, major bleeding; ❌ stroke/embolism
December 2, 2024 at 2:24 PM
#JournalWatch #Cardiology
📌 Network Meta-Analysis of 4 pivotal RCTs of DOACs vs warfarin in AF
👉 Standard-dose DOACs: ⬇️ stroke/embolism, death, intracranial bleeding; ❌ major bleeding
👉 Low-dose DOACs: ⬇️ death, intracranial bleeding, major bleeding; ❌ stroke/embolism
📌 Network Meta-Analysis of 4 pivotal RCTs of DOACs vs warfarin in AF
👉 Standard-dose DOACs: ⬇️ stroke/embolism, death, intracranial bleeding; ❌ major bleeding
👉 Low-dose DOACs: ⬇️ death, intracranial bleeding, major bleeding; ❌ stroke/embolism
#JournalWatch #CHD
👥 105 pt w RVOT dysfunction undergoing PPVI (median age 19.2 yrs)
👉 PPVI associated w ⬇️ RA size and improved RA emptying
👉 However, RA emptying not predictive of recovery of pVO2 or RVEF!
👥 105 pt w RVOT dysfunction undergoing PPVI (median age 19.2 yrs)
👉 PPVI associated w ⬇️ RA size and improved RA emptying
👉 However, RA emptying not predictive of recovery of pVO2 or RVEF!
December 2, 2024 at 2:24 PM
#JournalWatch #CHD
👥 105 pt w RVOT dysfunction undergoing PPVI (median age 19.2 yrs)
👉 PPVI associated w ⬇️ RA size and improved RA emptying
👉 However, RA emptying not predictive of recovery of pVO2 or RVEF!
👥 105 pt w RVOT dysfunction undergoing PPVI (median age 19.2 yrs)
👉 PPVI associated w ⬇️ RA size and improved RA emptying
👉 However, RA emptying not predictive of recovery of pVO2 or RVEF!
#JournalWatch #CHD
👥 cross-sectional and longitudinal cohorts of pediatric and adult PAH-CHD
👉 endostatin associated w shorter 6MWT, increased RAP, higher PAP and PVRi, RV dilation and dysfunction, worse Tx-free survival
👉 improved risk stratification when added to NT-proBNP
👥 cross-sectional and longitudinal cohorts of pediatric and adult PAH-CHD
👉 endostatin associated w shorter 6MWT, increased RAP, higher PAP and PVRi, RV dilation and dysfunction, worse Tx-free survival
👉 improved risk stratification when added to NT-proBNP
December 2, 2024 at 2:23 PM
#JournalWatch #CHD
👥 cross-sectional and longitudinal cohorts of pediatric and adult PAH-CHD
👉 endostatin associated w shorter 6MWT, increased RAP, higher PAP and PVRi, RV dilation and dysfunction, worse Tx-free survival
👉 improved risk stratification when added to NT-proBNP
👥 cross-sectional and longitudinal cohorts of pediatric and adult PAH-CHD
👉 endostatin associated w shorter 6MWT, increased RAP, higher PAP and PVRi, RV dilation and dysfunction, worse Tx-free survival
👉 improved risk stratification when added to NT-proBNP